Our Pricing

Understanding Mounjaro Dosage: Complete UK Dosing Guide

Understanding the correct mounjaro dosage is essential for achieving optimal weight loss results while minimising side effects. Mounjaro (tirzepatide) follows a carefully structured dose escalation schedule designed to improve tolerability as your body adapts to this dual GIP/GLP-1 receptor agonist. At Cured Pharmacy, our UK-registered clinical team provides comprehensive dosing guidance alongside the most competitive pricing in the UK, with Mounjaro available from £124.99 and £20 off your first order using code Weightlossnew.

What Is the Starting Mounjaro Dosage?

Initial 2.5mg Dose Protocol

The starting mounjaro dosage is always 2.5mg administered once weekly via subcutaneous injection. This initial dose serves as an initiation phase rather than a therapeutic dose, allowing your body to adjust to tirzepatide's metabolic effects with minimal gastrointestinal side effects [1]. Clinical trials in the SURPASS programme demonstrated that starting at 2.5mg significantly reduced the incidence of nausea and vomiting compared to higher initial doses.

You should maintain the 2.5mg mounjaro dosage for exactly four weeks before escalating. This four-week period is critical for building tolerance to the medication's effects on gastric emptying and appetite regulation. During this phase, many patients notice modest appetite suppression, though significant weight loss typically occurs at higher maintenance doses [2].

Mounjaro Dosage Escalation Schedule Explained

The mounjaro dosage escalation follows a structured four-week increment protocol: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg. Each dose increase occurs after four weeks at the current dose, subject to tolerability and clinical assessment by your prescriber [3]. This gradual escalation minimises gastrointestinal side effects whilst allowing your body to adapt to progressively stronger appetite suppression and metabolic changes.

Your prescriber may adjust the mounjaro dosage escalation timeline based on your individual response and side effect profile. Some patients remain at intermediate doses like 5mg or 7.5mg if they achieve their weight loss goals with minimal side effects, whilst others progress to the maximum 15mg dose for enhanced efficacy. In the SURPASS-1 trial, dose-dependent weight reductions were observed, with higher doses generally producing greater weight loss outcomes [1].

It is essential never to skip dose increments or accelerate the escalation schedule without explicit guidance from your UK-registered prescriber. Rushing the mounjaro dosage progression significantly increases the risk of severe nausea, vomiting, and treatment discontinuation. Each four-week interval allows your gastrointestinal system to adapt to the medication's effects on gastric motility and satiety signalling.

Maximum Mounjaro Dosage and Maintenance Doses

15mg Maximum Licensed Dose

The maximum mounjaro dosage licensed in the UK is 15mg once weekly. Clinical trials demonstrated that 15mg tirzepatide produced average weight reductions of 20.9% from baseline body weight over 72 weeks in the SURMOUNT-1 trial [4]. However, many patients achieve their target weight loss at lower maintenance doses such as 10mg or 12.5mg, which may offer a better balance between efficacy and tolerability.

Your maintenance mounjaro dosage will be determined through ongoing clinical assessment with your prescriber. Some individuals maintain their weight loss effectively on 5mg or 7.5mg, whilst others require 12.5mg or 15mg for sustained appetite control and metabolic benefits. Regular monitoring of weight loss progress, side effects, and metabolic markers helps optimise your long-term dosing strategy.

How to Administer Your Mounjaro Dosage Correctly

Administering your mounjaro dosage correctly ensures optimal absorption and reduces injection site reactions. Mounjaro is delivered via a pre-filled single-dose pen injected subcutaneously into the abdomen, thigh, or upper arm. Rotate injection sites weekly to prevent lipodystrophy and maintain consistent absorption rates [2]. Each pen contains one dose and should be used only once before disposal in a sharps container.

The mounjaro dosage should be administered on the same day each week, at any time of day, with or without food. If you miss a dose and it has been less than four days since your scheduled injection, administer it as soon as you remember. If more than four days have passed, skip the missed dose and resume your regular schedule. Never double your mounjaro dosage to compensate for a missed injection, as this significantly increases the risk of severe gastrointestinal side effects.

Before injecting, allow the Mounjaro pen to reach room temperature for approximately 30 minutes. Injecting cold medication can cause discomfort and may affect absorption. Always inspect the solution through the pen window—it should be clear and colourless. Do not use the pen if the solution appears cloudy, discoloured, or contains particles.

Mounjaro Dosage Side Effects and Management

Dose-Related Gastrointestinal Effects

Gastrointestinal side effects are directly related to mounjaro dosage strength, with nausea, vomiting, and diarrhoea being most common during dose escalation periods [3]. These effects typically peak within the first few days after a dose increase and gradually subside as your body adapts. In clinical trials, approximately 30-40% of participants experienced nausea at higher doses, though most cases were mild to moderate and transient.

Managing mounjaro dosage-related side effects involves eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated. If side effects become intolerable, your prescriber may recommend remaining at your current dose for an additional four weeks before escalating, or reducing to the previous dose temporarily. Persistent severe symptoms warrant immediate clinical review to assess whether Mounjaro remains appropriate for you.

Mounjaro Dosage Pricing and Access at Cured Pharmacy

At Cured Pharmacy, Mounjaro is available from £124.99 regardless of mounjaro dosage strength, with new patients receiving £20 off their first order using code Weightlossnew. This transparent pricing structure means you pay the same competitive rate whether you require the 2.5mg starting dose or the 15mg maximum dose. All prices are displayed upfront before your clinical consultation, with no hidden fees or subscription requirements.

Accessing the correct mounjaro dosage begins with a free online consultation with our UK-registered clinical team, which takes under three minutes to complete. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all prescribing decisions to ensure clinical appropriateness and safety. Once approved, your medication is dispensed from our GPhC-registered pharmacy (9012511) and delivered discreetly to your door with next-day delivery options available.

We supply only genuine UK-licensed Mounjaro manufactured by Eli Lilly, ensuring you receive authentic medication at every mounjaro dosage level. Our clinical team provides ongoing support throughout your treatment journey, including guidance on dose escalation timing, side effect management, and long-term weight maintenance strategies. You can contact our pharmacy team on (+44) 116 4646009 for any dosing questions or clinical concerns.

Scientific References

1. Rosenstock, J., Wysham, C., Frías, J. P., Kaneko, S., Lee, C. J., Fernández Landó, L., Mao, H., Cui, X., Karanikas, C. A., & Thieu, V. T. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155.
2. Eli Lilly and Company. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency (MHRA).
3. Dahl, D., Onishi, Y., Norwood, P., Huh, R., Bray, R., Patel, H., & Rodríguez, Á. (2022). Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial. JAMA, 327(6), 534-545.
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.